Literature DB >> 3889573

Strong adjuvanticity of bacterial lipopolysaccharides possessing the homopolysaccharides consisting of mannose as the O-specific polysaccharide chains.

N Kato, M Ohta, N Kido, S Naito, I Nakashima, F Nagase, T Yokochi.   

Abstract

The lipopolysaccharides (LPS) from Klebsiella 03 and 05 and Escherichia coli 08 and 09 are unique in having linear homopolysaccharides consisting of mannose as the O-specific polysaccharide chains. All four kinds of LPS were found to exhibit very strong adjuvanticity in induction of delayed-type hypersensitivity to ovalbumin in mice compared with other kinds of LPS from Klebsiella, E. coli and Salmonella. Even if the natural forms of Klebsiella 03 LPS and 01 LPS were converted to various defined uniform salt forms, their adjuvanticity did not differ significantly from that of the respective natural forms. It was concluded therefore that the difference in strength of the adjuvanticity between them is not due to the difference in their salt forms, solubility and physical state. Correspondingly, with strong adjuvanticity of Klebsiella 03 LPS and 05 LPS, their activity in enlarging the regional lymph node was also strong. Various uniform salt forms of Klebsiella 03 LPS caused stronger regional lymph node enlargement than those of Klebsiella 01 LPS. However, the activity of E. coli 08 LPS and 09 LPS in enlarging the regional lymph node was significantly weaker than that of Klebsiella 03 LPS and 05 LPS, and there were other kinds of LPS which showed a capacity to enlarge the regional lymph node similar to that of E. coli 08 LPS and 09 LPS, despite their weak adjuvanticity. Therefore, correlation did not necessarily exist between the degree of adjuvanticity of LPS and its activity in enlarging the regional lymph node.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889573

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

1.  Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.

Authors:  A Robert; H Jouin; J M Fournier
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  A new mouse model for autoimmune orchitis.

Authors:  Y Fujii; T Yokochi; I Nakashima; J Asai; N Kato
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Applications of polysaccharides. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-04       Impact factor: 2.926

4.  A murine model of experimental autoimmune lens-induced uveitis using Klebsiella O3 lipopolysaccharide as a potent immunological adjuvant.

Authors:  T Yokochi; Y Fujii; I Nakashima; J Asai; M Kiuchi; K Kojima; N Kato
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

5.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.

Authors:  T Yokochi; M Fukada; M Kawai; Y H Zhang; G Z Jiang; K Takahashi
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.

Authors:  M Nadai; T Hasegawa; K Kato; L Wang; T Nabeshima; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Murine experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein and Klebsiella pneumoniae 03 lipopolysaccharide (K03-LPS): a relation between H-2 haplotype and EAU induction.

Authors:  K Ando; J H Yamamoto; Y Fujino; N Kato; M Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-02       Impact factor: 3.117

9.  Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.

Authors:  N Paeng; N Kido; G Schmidt; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides.

Authors:  M Ohta; N Kido; T Hasegawa; H Ito; Y Fujii; Y Arakawa; T Komatsu; N Kato
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.